Friday, January 28, 2022 9:55:39 AM
GRPS is a products-based company offering alternatives to toxic pharmaceuticals to improve quality of life. With a unique staff of physicians, business executives and formulations experts, we have developed products for discomfort, sleep, anxiety, energy and other concerns that are game changers in a market that is well over a trillion dollars. Our products have been constructed utilizing strategic extraction techniques that are years in the making and clinical experience that have come together to focus on urgent consumer needs. Unlike other commercial products that fail to deliver, we pride ourselves on delivering products that yield results and are effective immediately. As an example is our Painplex product that delivers relief acting on different pathways than the CB1 and CB2 receptors addressed by our Relief Gummy. The combination is a never before offered solution to the opioid concern. As a licensed government contractor, we have drawn the attention of several agencies with our products and expect not only a strong distribution opportunity but will be gladly obligated to prove efficacy within this framework as well. While Sleepy Watermelon, Relief Raspberry, and Calming Mango are products that we now have formulated and produced, we have finished Research and Development on Painplex, Energyplex, Inflammaplex and Longevityplex and look forward to the first of these products for public consumption in the very near term.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM